Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Regulator strikes out two-year requirement as registered pharmacist for IP training in Northern Ireland

The Council of the Pharmaceutical Society NI (PSNI) to remove the two-year requirement as a registered pharmacist to have an Independent Prescriber (IP) annotation on the pharmacy register in Northern Ireland.

It has further endorsed that the two-year requirement for entry onto stand-alone pharmacist independent prescribing courses be removed and replaced with an assessment before admission, by course providers, based upon guidance provided by the regulator.


In conjunction with the Department of Health, the PSNI will now work towards a further public consultation on the necessary legislative changes.

Dr Jim Livingstone, president of the PSNI, said: “The Department of Health has set a clear direction which will see pharmacist independent prescribers becoming increasingly important in the delivery of pharmacy services in Northern Ireland. Our role is to protect the public, but we are clear that our regulatory objective should not be an unnecessary barrier to the development of the profession and enhanced services being provided to the public."

The council’s recent public consultation outlined proposals on changes to the entry requirements for standalone independent prescribing courses and annotation as an IP on the register. The proposals sought to strike a right balance between protecting the public, whilst not placing disproportionate regulatory barriers in the way of developing services.

“I am pleased that our proposals were broadly supported,” Dr Livingstone said, adding: “Removing the two-year period before being annotated on the Register is necessary to deliver wider reforms to pharmacy education. We will continue to work with the Department of Health, to move towards a public consultation on the necessary legislative changes.

“We acknowledge the feedback received, that some further clarification and guidance is required in certain areas, and we have committed to working with our colleagues in the GPhC to develop guidance for course providers and others.

“We are also committed to exploring what additional support might be needed for independent prescribers in relation to post-registration education and professional development. We will take this work on as part of our partnership with the GPhC on the UK wide post-registration assurance of practise group. Ensuring that there is appropriate engagement and involvement with local stakeholders.

“We had several excellent responses to this consultation, which raised important issues. A number of these issues related to the wider education reform agenda and are outside the immediate responsibility of the Regulator. We have, however, committed to presenting our consultation report to the Education Reform Implementation Group, which is progressing these wider reforms in Northern Ireland.”

More For You

Lynsey Cleland named GPhC chief standards officer

Lynsey Cleland

Pic credit: X

Lynsey Cleland named GPhC chief standards officer

The General Pharmaceutical Council (GPhC) has brought back Lynsey Cleland to lead on a number of important departments in the role of chief standards officer.

Cleland had previously held a number of senior positions at GPhC, including director of Scotland.

Keep ReadingShow less
Pharma industry group unhappy with NHS drug pricing offer

The ABPI warned that £2 billion of potential investment could be under risk

Pic credit: istock

Pharma industry group unhappy with NHS drug pricing offer

The Association of the British Pharmaceutical Industry (ABPI) has rejected the UK government’s offer to cut the cost of NHS drugs pricing scheme as it felt it was inadequate.

The industry group warned that £2 billion of potential investment could be under risk and wanted prime minister Keir Starmer to intervene, The Times reports.

Keep ReadingShow less
Day Lewis celebrates 50 years of delivering care to communities

The Patel family at the unveiling of the commemorative plaque ceremony

Day Lewis celebrates 50 years of delivering care to communities

Day Lewis honoured "the people, purpose and partnerships" as it celebrated 50 years of service by unveiling a commemorative plaque at the company’s support office in Croydon.

As one of the UK’s largest independent pharmacy chains, Day Lewis has delivered trusted care to communities across the country since it was founded in 1975, by brothers Kirit and JC Patel, who was on hand to unveil the plaque.

Keep ReadingShow less
CPE said the committee’s discussions are fully shaped by pharmacy owners’ views and experiences

CPE said the committee’s discussions are fully shaped by pharmacy owners’ views and experiences

Pic credit: iStock

Pharmacy owners asked to share views on new contract and its financial implications

Pharmacy owners can share their thoughts on service developments and their financial security before the upcoming Community Pharmacy England (CPE) committee meeting to be held on June 25 and 26.

The new Community Pharmacy Contractual Framework (CPCF) was completed in March with the various service and regulatory changes still in progress.

Keep ReadingShow less
Cancer treatment impact

There have been supply issues with Creon since the summer of 2024

Pic credit: iStock

Cancer patients struggle amid digestive drug shortage

Pharmacists in the Channel Islands have revealed that there is a shortage of a drug used to support digestion in cancer patients.

Creon is a pancreatic enzyme replacement therapy (PERT), which helps people living with conditions such as cystic fibrosis, pancreatitis, and pancreatic cancer to digest food.

Keep ReadingShow less